The short answer: burnt toast contains more acrylamide, a chemical that causes cancer in animals at very high doses, but large reviews of human studies mostly find no link between dietary acrylamide and cancer. The evidence in people is observational and imprecise, so food-safety agencies still advise keeping exposure low. Toasting to golden rather than dark brown, and scraping off or discarding charred bits, is the simple way to do that.
Why Browner Toast Has More Acrylamide
Acrylamide forms when sugars react with the amino acid asparagine at high heat. FDA describes it as a substance that forms “through a natural chemical reaction between sugars and asparagine” in plant-based foods, including “potato and cereal-grain-based foods,” during frying, roasting and baking. It’s part of the same browning chemistry that gives toast its color and flavor, so the darker the toast, the more acrylamide.
EFSA, the European Food Safety Authority, notes that toasting bread for a couple of extra minutes can raise acrylamide substantially, depending on the bread and the toaster. It also reports that adults’ main dietary sources are fried potato products and coffee, followed by soft bread, biscuits, crackers and crispbreads.
What the Agencies Say
| Agency | Position |
|---|---|
| IARC (World Health Organization) | Group 2A, “probably carcinogenic to humans,” based on sufficient evidence in animals and inadequate evidence in humans (1994). |
| EFSA (2015 scientific opinion) | Acrylamide in food “potentially increases the risk of developing cancer for consumers in all age groups.” |
| FDA | Acrylamide “has been shown to cause cancer in animals exposed to very high doses,” and it is “not clear exactly what risk acrylamide poses to humans.” |
The animal doses that cause tumors are far above what people eat. That’s why the agencies frame acrylamide as a reason to reduce exposure, not as a proven cause of cancer from food.
What Reviews of Human Studies Found
Searching Europe PMC for systematic reviews and meta-analyses of dietary acrylamide and cancer turns up these:
| Review | Studies | Finding |
|---|---|---|
| Filippini et al., 2022, Frontiers in Nutrition | 16 studies, 1,151,189 people, 48,175 cancers, median 14.9 years of follow-up; mean intake 23 µg/day | No association between highest and lowest intake and any non-gynecological cancer site, and no threshold in the dose-response analysis. Lung cancer risk was higher only among smokers. |
| Pelucchi et al., 2015, International Journal of Cancer | 32 publications, 14 cancer sites | Highest vs. lowest intake near RR 1.0 for most cancers. Kidney RR 1.20 (95% CI 1.00–1.45) was borderline. In never-smokers, endometrial RR 1.23 (1.00–1.51) and ovarian RR 1.39 (0.97–2.00). Per 10 µg/day, RRs 0.95–1.03, none significant. |
| Adani et al., 2020, Cancer Epidemiology, Biomarkers & Prevention | 18 papers, 10 populations (16 cohort, 2 case-control) | Slightly higher ovarian and endometrial cancer risk with higher intake, especially in never-smokers; no association with breast cancer except in premenopausal women. |
| Benisi-Kohansal et al., 2021, British Journal of Nutrition | 14 prospective cohorts | No significant association with breast (RR 0.95, 0.90–1.01), endometrial (RR 1.03, 0.89–1.19) or ovarian cancer (RR 1.02, 0.84–1.24). |
| Jiang et al., 2020, Journal of the Science of Food and Agriculture | 8 studies, 2,843 kidney cancer cases | No meaningful association with renal cell carcinoma: RR 1.12 (0.97–1.28); never-smokers RR 1.11 (0.93–1.32). |
Evidence quality: moderate at best. All of these pool observational cohort and case-control studies. They estimate acrylamide intake from food-frequency questionnaires, which measure it poorly, and there are no trials. The results are mostly null, with a few borderline signals for kidney, endometrial and ovarian cancer that later reviews didn’t confirm consistently.
No review covers toast itself. None of these studies measured cancer risk from eating burnt or dark toast specifically; they estimate total acrylamide from all foods. A 2024 systematic review of acrylamide and cardiovascular risk (Mérida et al., 28 mostly cross-sectional studies) found mixed associations and doesn’t settle that question either.
Practical Advice
- Toast to golden, not dark brown. EFSA notes that some national authorities advise “Don’t burn it, lightly brown it.”
- Scrape off or skip the charred parts rather than eating very dark toast regularly.
- Use the bagel and frozen settings properly so you’re not running a second cycle that darkens the outside. If your toaster browns unevenly, see why toasters toast unevenly.
- Keep perspective: fried potatoes and coffee contribute more acrylamide to most adults’ diets than bread does.
No toaster maker in our research claims its toaster reduces acrylamide.
Burnt Toast FAQ
Does burnt toast cause cancer?
There’s no direct evidence that it does in people. Burnt toast has more acrylamide, which causes cancer in animals at very high doses, but meta-analyses of human diets mostly find no link between acrylamide intake and cancer.
Is it OK to eat slightly burnt toast?
Occasionally, yes. Agencies advise keeping acrylamide intake low over time, so toasting lighter and scraping off charred spots is a reasonable habit rather than an urgent risk.
Does scraping burnt toast help?
It removes the darkest surface, where browning chemistry is most advanced. No study measured how much acrylamide scraping removes.
Is acrylamide in toast worse than in fries or coffee?
EFSA lists fried potato products and coffee as adults’ main sources, with soft bread, biscuits, crackers and crispbreads next.
What does IARC say about acrylamide?
IARC classifies it as Group 2A, “probably carcinogenic to humans,” based on animal evidence; human evidence was judged inadequate.
Sources
- FDA: Acrylamide
- EFSA: Acrylamide topic page and 2015 scientific opinion
- IARC Monograph 60: Acrylamide
- Filippini T, et al. Dietary acrylamide exposure and risk of site-specific cancer. Front Nutr. 2022 (PubMed 35548558)
- Pelucchi C, et al. Dietary acrylamide and cancer risk: an updated meta-analysis. Int J Cancer. 2015 (PubMed 25403648)
- Adani G, et al. Dietary intake of acrylamide and risk of breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev. 2020 (PubMed 32169997)
- Benisi-Kohansal S, et al. Dietary acrylamide intake and risk of women’s cancers. Br J Nutr. 2021 (PubMed 33413725)
- Jiang F, et al. No association between dietary acrylamide and renal cell carcinoma. J Sci Food Agric. 2020 (PubMed 32077494)
- Mérida DM, et al. Acrylamide exposure and cardiovascular risk: a systematic review. Nutrients. 2024 (PubMed 39770901)





